Cite
MLA Citation
Y Guo et al.. “Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial.” Annals of oncology, vol. 30, 2019, pp. 1831–1839. http://access.bl.uk/ark:/81055/vdc_100099397754.0x000031